Philippe Billiald

Orsay, 91400, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Identification of a common epitope in knottins and phospholipases D present in Loxosceles sp venom by a monoclonal antibody.

Identification of a common epitope in knottins and phospholipases D present in Loxosceles sp venom by a monoclonal antibody.

Journal: International journal of biological macromolecules

Published: February 24, 2023

An effective strategy for the humanization of antibody fragments under an accelerated timeline.

An effective strategy for the humanization of antibody fragments under an accelerated timeline.

Journal: International journal of biological macromolecules

Published: May 11, 2022

Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition.

Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition.

Journal: Blood advances

Published: April 14, 2022

Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential.

Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential.

Journal: Toxins

Published: March 20, 2020

Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet Aggregation.

Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet Aggregation.

Journal: Journal of clinical pharmacology

Published: November 29, 2019

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab.

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: April 25, 2019

Engineering a single-chain antibody against Trypanosoma cruzi metacyclic trypomastigotes to block cell invasion.

Engineering a single-chain antibody against Trypanosoma cruzi metacyclic trypomastigotes to block cell invasion.

Journal: PloS one

Published: April 03, 2019

Biomolecular engineering of antidehydroepiandrosterone antibodies: a new perspective in cancer diagnosis and treatment using single-chain antibody variable fragment.

Biomolecular engineering of antidehydroepiandrosterone antibodies: a new perspective in cancer diagnosis and treatment using single-chain antibody variable fragment.

Journal: Nanomedicine (London, England)

Published: January 30, 2019

Antibody Fragments Humanization: Beginning with the End in Mind.

Antibody Fragments Humanization: Beginning with the End in Mind.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 13, 2018

Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development.

Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development.

Journal: New biotechnology

Published: February 13, 2018

Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks.

Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks.

Journal: mAbs

Published: June 10, 2017

Generation of recombinant antibody fragments with toxin-neutralizing potential in loxoscelism.

Generation of recombinant antibody fragments with toxin-neutralizing potential in loxoscelism.

Journal: Immunology letters

Published: March 08, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026